Literature DB >> 17037540

Human coronavirus 229E can use CD209L (L-SIGN) to enter cells.

Scott A Jeffers1, Erin M Hemmila, Kathryn V Holmes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17037540      PMCID： PMC7123611          DOI： 10.1007/978-0-387-33012-9_44

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  12 in total

Review 1.  The plasma membrane as a combat zone in the HIV battlefield.

Authors:  R W Doms; D Trono
Journal:  Genes Dev       Date:  2000-11-01       Impact factor: 11.361

Review 2.  Collectins: players of the innate immune system.

Authors:  J Koenraad van de Wetering; Lambert M G van Golde; Joseph J Batenburg
Journal:  Eur J Biochem       Date:  2004-04

3.  DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus.

Authors:  Andrea Marzi; Thomas Gramberg; Graham Simmons; Peggy Möller; Andrew J Rennekamp; Mandy Krumbiegel; Martina Geier; Jutta Eisemann; Nadine Turza; Bertrand Saunier; Alexander Steinkasserer; Stephan Becker; Paul Bates; Heike Hofmann; Stefan Pöhlmann
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN.

Authors:  Monica T Yu Kimata; Marina Cella; Julia E Biggins; Colin Rorex; Robert White; Sarah Hicks; Joelle M Wilson; Parul G Patel; Jonathan S Allan; Marco Colonna; Jason T Kimata
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme.

Authors:  Dan Harmer; Maureen Gilbert; Richard Borman; Kenneth L Clark
Journal:  FEBS Lett       Date:  2002-12-04       Impact factor: 4.124

6.  Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I.

Authors:  D B Tresnan; R Levis; K V Holmes
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

7.  CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.

Authors:  Scott A Jeffers; Sonia M Tusell; Laura Gillim-Ross; Erin M Hemmila; Jenna E Achenbach; Gregory J Babcock; William D Thomas; Larissa B Thackray; Mark D Young; Robert J Mason; Donna M Ambrosino; David E Wentworth; James C Demartini; Kathryn V Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-20       Impact factor: 11.205

8.  Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site.

Authors:  Erik Lontok; Emily Corse; Carolyn E Machamer
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Mouse hepatitis virus replicase protein complexes are translocated to sites of M protein accumulation in the ERGIC at late times of infection.

Authors:  A G Bost; E Prentice; M R Denison
Journal:  Virology       Date:  2001-06-20       Impact factor: 3.616

10.  Human aminopeptidase N is a receptor for human coronavirus 229E.

Authors:  C L Yeager; R A Ashmun; R K Williams; C B Cardellichio; L H Shapiro; A T Look; K V Holmes
Journal:  Nature       Date:  1992-06-04       Impact factor: 49.962
View more
  22 in total

1.  Feline lectin activity is critical for the cellular entry of feline infectious peritonitis virus.

Authors:  Andrew D Regan; David G Ousterout; Gary R Whittaker
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

2.  Glycan Shield and Fusion Activation of a Deltacoronavirus Spike Glycoprotein Fine-Tuned for Enteric Infections.

Authors:  Xiaoli Xiong; M Alejandra Tortorici; Joost Snijder; Craig Yoshioka; Alexandra C Walls; Wentao Li; Andrew T McGuire; Félix A Rey; Berend-Jan Bosch; David Veesler
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

3.  Utilization of DC-SIGN for entry of feline coronaviruses into host cells.

Authors:  Andrew D Regan; Gary R Whittaker
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

4.  Expression of the C-type lectins DC-SIGN or L-SIGN alters host cell susceptibility for the avian coronavirus, infectious bronchitis virus.

Authors:  Yueting Zhang; Elizabeth Buckles; Gary R Whittaker
Journal:  Vet Microbiol       Date:  2012-01-17       Impact factor: 3.293

5.  Feline and canine coronaviruses: common genetic and pathobiological features.

Authors:  Sophie Le Poder
Journal:  Adv Virol       Date:  2011-07-31

Review 6.  Mechanisms of coronavirus cell entry mediated by the viral spike protein.

Authors:  Sandrine Belouzard; Jean K Millet; Beth N Licitra; Gary R Whittaker
Journal:  Viruses       Date:  2012-06-20       Impact factor: 5.048

7.  Coronaviruses' sugar shields as vaccine candidates.

Authors:  Denong Wang
Journal:  Curr Trends Immunol       Date:  2020

Review 8.  Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.

Authors:  Seyed Abdulmajid Ayatollahi; Javad Sharifi-Rad; Patrick Valere Tsouh Fokou; Gail B Mahady; Hafiz Ansar Rasul Suleria; Shivani Krishna Kapuganti; Kundlik Gadhave; Rajanish Giri; Neha Garg; Rohit Sharma; Daniel Ribeiro; Célia F Rodrigues; Željko Reiner; Yasaman Taheri; Natália Cruz-Martins
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

9.  CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2.

Authors:  Razie Amraei; Wenqing Yin; Marc A Napoleon; Ellen L Suder; Jacob Berrigan; Qing Zhao; Judith Olejnik; Kevin Brown Chandler; Chaoshuang Xia; Jared Feldman; Blake M Hauser; Timothy M Caradonna; Aaron G Schmidt; Suryaram Gummuluru; Elke Mühlberger; Vipul Chitalia; Catherine E Costello; Nader Rahimi
Journal:  ACS Cent Sci       Date:  2021-06-30       Impact factor: 18.728

10.  Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy.

Authors:  Alexandra C Walls; M Alejandra Tortorici; Brandon Frenz; Joost Snijder; Wentao Li; Félix A Rey; Frank DiMaio; Berend-Jan Bosch; David Veesler
Journal:  Nat Struct Mol Biol       Date:  2016-09-12       Impact factor: 15.369
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.